Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04447339 · ClinicalTrials.gov registry record

Open Nipple Sparing Mastectomy (NSM)

A clinical trial, sponsored by Intuitive Surgical.

Active
Registry status
75
Enrollment target

NCT04447339: Active study, sponsored by Intuitive Surgical.

NCT04447339 is a clinical trial that is active but no longer recruiting, run by Intuitive Surgical. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04447339 is active but no longer recruiting, sponsored by Intuitive Surgical.

ACTIVE NOT RECRUITING
Registry status
75 participants
Enrollment target

Study Summary

This is retrospective, multicenter chart review is to evaluate the complication rates of prophylactic open NSM procedures through 42 days postoperatively

Primary Outcome

To assess the number of open prophylactic nipple sparing mastectomy complications compared to the number of procedures

Interventions

  • PROCEDURE Nipple Sparing Mastectomy

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2020-09-21
Est. Completion 2026-12-31
Intuitive Surgical

40 total trials

What the registry record for NCT04447339 still lists

NCT04447339 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Nipple Sparing Mastectomy is the first listed.

NCT04447339 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04447339 about?

NCT04447339 is a clinical study titled "Open Nipple Sparing Mastectomy (NSM)". This is retrospective, multicenter chart review is to evaluate the complication rates of prophylactic open NSM procedures through 42 days postoperatively

What is the current status of trial NCT04447339?

This trial is currently active not recruiting. The enrollment target is 75 participants. The study started on 2020-09-21. Estimated completion is 2026-12-31.

What interventions are being tested in trial NCT04447339?

The interventions under investigation include: Nipple Sparing Mastectomy (PROCEDURE).

Who is sponsoring clinical trial NCT04447339?

This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04447339, the US trial registry maintained by the National Library of Medicine. NCT04447339 (small enrollment · none site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.